Patent application number | Description | Published |
20090023738 | DIAMINOPYRIMIDINES AS MODULATORS OF THE EP2 RECEPTOR - The present invention relates to diaminopyrimidines of the general formula I, process for their preparation, and the use thereof for the manufacture of pharmaceutical compositions for the treatment of disorders and indications connected with the EP | 01-22-2009 |
20090023741 | ARYL/HETARYLAMIDES AS MODULATORS OF THE EP2 RECEPTOR - The present invention relates to aryl/hetarylamide derivatives of the general formula I, process for their preparation, and the use thereof for the manufacture of pharmaceutical compositions for the treatment of disorders and indications connected with the EP | 01-22-2009 |
20090042878 | THIENOPYRIMIDYLAMINES AS MODULATORS OF THE EP2 RECEPTOR - The present invention relates to thienopyrimidylamines of the general formula I, to processes for their preparation and to their use for production of pharmaceutical compositions for treatment of disorders and indications connected to the EP | 02-12-2009 |
20090042882 | SUBSTITUTED ACETAMIDES AS MODULATORS OF THE EP2 RECEPTOR - The present invention relates to substituted acetamides of the general formula I, process for their preparation, and the use thereof for the manufacture of pharmaceutical compositions for the treatment of disorders and indications connected with the EP | 02-12-2009 |
20090042913 | Indolylalkylthienopyrimidylamines as modulators of the EP2 receptor - The present invention relates to indolylalkylthienopyrimidylamines of the general formula I, to processes for their preparation and to their use for production of pharmaceutical compositions for treatment of disorders and indications connected to the EP | 02-12-2009 |
20090098189 | AZAINDOLES AS INHIBITORS OF SOLUBLE ADENYLATE CYCLASE - The present invention relates to azaindoles of general formula I, a method for the production thereof, and to the use thereof for the production of pharmaceutical compositions. | 04-16-2009 |
20100029598 | Extended Benzamide Derivatives as Modulators of the EP2 Receptor - The present invention relates to extended benzamide derivatives of the general formula I, to processes for preparation thereof and to use thereof for production of pharmaceutical compositions for treatment of disorders and indications associated with the EP | 02-04-2010 |
20100029599 | Indolylamides as modulators of the EP2 receptor - The present invention relates to indolylamide derivatives of the general formula (I), to processes for preparation thereof and to use thereof for production of pharmaceutical compositions for treatment of disorders and indications associated with the EP | 02-04-2010 |
20100168179 | 6-ALKENYL-, 6-ALKINYL- AND 6-EPOXY-EPOTHILONE DERIVATIVES, PROCESS FOR THEIR PRODUCTION, AND THEIR USE IN PHARMACEUTICAL PREPARATIONS - This invention describes the new 6-alkenyl- and 6-alkinyl-epothilone derivatives of general formula (I) in which R | 07-01-2010 |
20100248313 | NOVEL OPTICALLY ACTIVE, HETEROAROMATIC BETA-HYDROXY ESTERS AND PROCESSES FOR THEIR PREPARATION FROM BETA-KETO ESTERS AND PROCESSES FOR THE PREPARATION OF THESE BETA-KETO ESTERS - The present invention relates to new optically active heteroaromatic β-hydroxy esters useful in the synthesis of epothilone derivatives, to certain compounds used to produce these intermediates, as well as to processes for their production. | 09-30-2010 |
20110166168 | Sulphone-substituted quinazoline derivatives as immuno-modulators, their preparation and use as medicaments - The present invention relates to sulphone-substituted quinazoline derivatives of the formula (I), processes for their preparation and their use as a medicament for the treatment of various diseases. | 07-07-2011 |
20130190290 | Substituted phenylimidazopyrazoles and their use - The present application relates to novel 1-phenyl-1H-imidazo[1,2-b]pyrazole derivatives, to processes for their preparation, to their use for the treatment and/or prevention of diseases and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular angiogenic disorders and hyperproliferative disorders, where neovascularization plays a role, such as, for example, neoplastic disorders and tumour disorders. Such treatments can be carried out as monotherapy or else in combination with other medicaments or further therapeutic measures. | 07-25-2013 |
20140336172 | Novel 2H-Indazoles as EP2 Receptor Antagonists - The present invention relates to novel 2H-indazoles of the general formula (I), methods for the preparation thereof and the use thereof for the production of pharmaceutical agents for the treatment of diseases and indications which are linked with the EP | 11-13-2014 |